Arch Therapeutics Announces $2.85 Million Private Placement
31 janv. 2014 06h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 31, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Presents 2014 Milestones During Live Webcast
22 janv. 2014 11h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 22, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics to Present Status Update and Milestone Overview at Noble Financial Capital Markets' Tenth Annual Equity Conference
14 janv. 2014 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 14, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics to Webcast Live From the Biotech Showcase Investor Conference
08 janv. 2014 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 8, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of AC5™, a novel product aimed at...
Blood Banking And Blood Products - Global Strategic Business Report 2012-2018
20 nov. 2013 09h48 HE
|
Research and Markets
Dublin, Nov. 20, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/tlzw4c/blood_banking_and)
has announced the addition of the
"Blood Banking And Blood...
Blood Processing Supplies And Equipment
15 nov. 2013 10h32 HE
|
Research and Markets
Dublin, Nov. 15, 2013 (GLOBE NEWSWIRE) -- Blood Processing Supplies And Equipment - Global
Strategic Business Report - 2012
Research and Markets...
Blood Pressure Monitoring And Measurement Instruments - Global Strategic Business Report 2013
07 nov. 2013 09h36 HE
|
Research and Markets
Dublin, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/kf8bt2/blood_pressure)
has announced the addition of the "Blood
Pressure Monitoring And...
Arch Therapeutics Co-Founder Dr. Ellis-Behnke to Speak at Nanomanufacturing Summit 2013 in Philadelphia, October 15, 2013
10 oct. 2013 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Oct 10, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), is pleased to announce that co-founding and inventing scientist, Dr. Rutledge...
Arch Therapeutics Announces Approval of $1 Million Massachusetts Life Sciences Center Accelerator Loan
07 oct. 2013 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Oct 7, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of AC5™, a novel product aimed at...
Arch Therapeutics Announces Participation at the 2013 Boulder Peptide Symposium in Colorado September 25-27
20 sept. 2013 09h00 HE
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Sep 20, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), today announced it will be featured as a presenting company at the Boulder Peptide...